{"id":212762,"name":"IMMUNITYBIO, INC.","slug":"immunitybio-inc","state":"CA","country":"United States of America","description":"Late-stage, cell therapy and immunotherapy co. focused on oncology & infectious disease","totalSpending":210000,"filings":5,"yearlySpending":[{"year":2021,"income":60000},{"year":2022,"income":150000}],"issues":["MED","SCI","HCR"],"firms":["THE PETRIZZO GROUP, INC."],"lobbyists":["TJ PETRIZZO","MEGAN PEREZ BURKE"],"govEntities":["Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","Natl Institutes of Health (NIH)","SENATE","White House Office","Defense, Dept of (DOD)"],"sampleDescriptions":["New Technologies for Accessible, Durable, and Broadly Protective 2nd Generation Coronavirus Vaccines","New Technologies for Accessible, Durable, and Broadly Protective 2nd Generation Coronavirus Vaccines","New Technologies for Accessible, Durable, and Broadly Protective 2nd Generation Coronavirus Vaccines","Federal support for next generation COVID-19 vaccine technology development, approval and distribution.","Federal support for next generation COVID-19 vaccine technology development, approval and distribution."],"years":[2021,2022]}